- Investor Relations
Medios acquires NewCo Pharma Group
Medios expands its market position in compounding and taps new growth potentials
Think about tomorrow
Sustainability strategy published – comprehensive Sustainability program to be implemented by 2025
All Information regarding Corporate Development
Quarterly Statement as of September 30, 2022
Annual General Meeting of Medios AG
The Annual General Meeting 2022 of Medios AG was take place on June 21, 2022 as a virtual Annual General Meeting. You can find essential information here.
Dates and Events
For Maximum Transparency
Medios AG is one of the best-known companies in the growth market of specialty pharmaceuticals in Germany.
Specialty pharma medicinal products are medicines for patients with rare or chronic diseases such as cancer, HIV, hepatitis or hemophilia.
Our work centers on patient wellbeing.
Medios AG is Germany's first specialty pharmaceutical company to be listed on the stock exchange.
Head of Investor & Public Relations
+49 30 232 566 800
Stay informed Receive e-mail updates on the latest news and the publication of financial reports. This will automatically keep you up to date.
Registration is free of charge and can be revoked at any time.